Top Trends Transforming the Adult Vaccines Market Landscape in 2025: Data Trend Platform To Enhance Adult Vaccination Efforts

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Adult Vaccines Industry Market Size Be by 2025?
The market size for adult vaccines has seen a robust growth in the past few years. The market is predicted to rise from a value of $22.82 billion in 2024 to $24.21 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The growth in the historical period is due to factors such as the rise in the aging population, government-sponsored vaccination programs, increased awareness towards preventive healthcare, innovations in vaccine development, and public health campaigns.

What's the Long-Term Growth Forecast for the Adult Vaccines Market Size Through 2029?
The market size of adult vaccines is anticipated to experience significant expansion in the forthcoming years, surging to "$34.19 billion by 2029. This represents a compound annual growth rate (CAGR) of around 9.0%. This projected growth in the forecast period can be associated with the emergence of new infectious threats, intensifying emphasis on immunization registries, escalating risk of antimicrobial resistance, global initiatives towards pandemic readiness, a shift towards personalized vaccines, and a rising focus on maternal immunization. Key trends anticipated during the forecast period involve the integration of digital health, advancements in vaccine production technology, collaborations encompassing governments and pharmaceutical companies, progressions in vaccine delivery technologies, and broadening immunization programs.

View the full report here:
https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

What Are the Key Growth Drivers Fueling the Adult Vaccines Market Expansion?
The growing occurrence of infectious diseases is propelling the advancement of the adult vaccine market. Infectious diseases can be effortlessly transmitted from one person to another. Vaccinations serve an essential role in enabling individuals to establish resistance towards such diseases, thus proving to be a highly potent strategy against infections. For example, data from the Centers for Disease Control and Prevention, a public health agency in the United States, revealed that in March 2023, there were 8,300 reported cases of tuberculosis in the United States, an increase from 7,874 cases in 2021. The prevalence of TB in 2022 saw a slight rise to 2.5 per 100,000 people, from 2.4 in the previous year. Hence, the escalating incidence of transmittable diseases is fostering the expansion of the adult vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Are the Key Trends Driving Adult Vaccines Market Growth?
The emergence of product innovations is a predominant trend among the adult vaccines market. The market's leading companies are promoting new and unique products to retain their market presence. For illustration, in August 2022, GSK, a biopharma firm from the UK, and IQVIA, an Indian global provider of sophisticated analytics, technology solutions, and clinical research services, unveiled Vaccine Track. This is a data trend platform designed to better adult immunization across communities nationwide. It is intended to deliver consistent and pertinent data on trends that require attention, thus boosting public health initiatives.

How Is the Adult Vaccines Market Segmented?
The adult vaccines market covered in this report is segmented -

1) By Vaccine Type: Monovalent, Multivalent
2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines
3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis
4) By End Users: Healthcare Firms, Hospitals

Subsegments:
1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines
2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

Which Companies Are Leading the Charge in Adult Vaccines Market Innovation?
Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Which Regions Are Leading the Global Adult Vaccines Market in Revenue?
North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9038

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.